ecancer
N

ESMO 2023 Insights: "Survival Results for Neoadjuvant Cemiplimab in Patients With Resectable CSCC"

By ecancer FEATURING Neil Gross
By ecancer FEATURING Neil Gross
0 views
November 3, 2023
Comments 0
Login to view comments. Click here to Login

Recommended

AUTOPLAY
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
09:00
AAD 2024 Insights

AAD 2024 Insights: What's New In Nail Tumors

Feat. J. Dominguez-Cherit
11:53
AAD 2024 Insights

AAD 2024 Insights: Immunomodulators in Non-Melanoma Skin Cancer

Feat. V. Patel
26:24
EADV 2023 Insights

EADV 2023 Insights: Non-Melanoma Skin Cancer Management in Organ Tra…

Feat. G. Hofbauer
13:21
NYU Langone

Management of High Risk Squamous Cell Carcinoma

Feat. M. L. Stevenson
21:20
Dana-Farber Cancer Institute

Year in Review: Updates in Non-Melanoma Skin Cancers

Feat. K. Khaddour
05:58
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Neoadjuvant Cemiplimab for Stage II to IV …

Feat. N. Gross
58:44
Head and Neck Symposium: Skin Malignancies Update

Updates in non-Melanoma Skin Cancer

Feat. S. Daveluy
47:34
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Fred Hutchinson Cancer Center Head & Neck Cancer Updates

Feat. C. Rodriguez
27:29
Total Health

2023 ASCO® Direct Philadelphia: Melanoma Updates

Feat. M. Orloff
15:39
ImmunoTherapy Bridge 2023

Neoadjuvant IO: Non-Melanoma Skin Cancer

Feat. N. Gross
23:44
Todd Schlesinger

PD-1 Inhibitors for Advanced Basal Cell Carcinoma and Squamous Cell …

15:54
ImmunoTherapy Bridge 2023

Non-Melanoma Skin Cancers

Feat. P. A. Ascierto
24:20
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "To Treat or Not to Treat - Challenging Sc…

Feat. K. Margolin
18:56
Yale Cancer Center

Immunotherapy and Anti-Angiogenic Therapies in HNSCC

Feat. A. Bhatia
12:13
AACR 2023 Conference Coverage

Clinical Activity of MCLA-158 (Petosemtamab), an IgG1 Bispecific Ant…

Feat. E. Cohen
09:00
Winship Cancer Institute - Emory University

Harnessing IO in the Management of CSCC

Feat. N. Saba
25:33
Houston Methodist Hospital

Update on HPV Testing in Head and Neck Cancer

Feat. M. R. Schwartz
15:09
ImmunoTherapy Bridge 2023

Best of SITC 2023 for Clinical Development and IO Trials

Feat. P. A. Ascierto
47:18
Nebraska Oncology Society

ASCO 2022 Review of Head & Neck Cancer Updates

Feat. E. Sherman